US FDA Board Formed To Manage Increasingly Complex Pharmaceutical Supply Chain Oversight

High-level board will bring together information from across FDA drug center and work to increase supply chain transparency, CDER’s Jacqueline Corrigan-Curay, who will chair the group, tells the Pink Sheet.